Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41392-020-00301-9 http://scihub22266oqcxt.onion/10.1038/s41392-020-00301-9 32879307!7464057!32879307     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Signal+Transduct+Target+Ther 2020 ; 5 (1): 180 Nephropedia Template TP {{tp|p=32879307|t=2020. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 |pdf=|usr=}}{{32879307}} gab.com Text Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 JO: Signal Transduct Target Ther http://www.kidney.de/pget.php?&tw=1&pmid=32879307 #FOAvip COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic, we observed the positive correlation between serum neutralizing capacity and disease severity, in particular, the highest NAb capacity in sera from the patients with severe disease, while a lack of ability of asymptomatic patients to mount competent NAbs. Furthermore, the compositions of NAb subtypes were also different between recovered patients with severe symptoms and with mild-to-moderate symptoms. These results reveal the tremendous heterogeneity of SARS-CoV-2-specific NAb responses and their correlations to disease severity, highlighting the needs of future vaccination in COVID-19 patients recovered from asymptomatic or mild illness. Twit Text FOAVip Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 ????Signal Transduct Target Ther http://www.kidney.de/pget.php?&tw=1&pmid=32879307 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32879307 #FOAvip English Wikipedia <ref>{{Cite pmid|32879307}}</ref> Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 #MMPMID32879307 Chen X; Pan Z; Yue S; Yu F; Zhang J; Yang Y; Li R; Liu B; Yang X; Gao L; Li Z; Lin Y; Huang Q; Xu L; Tang J; Hu L; Zhao J; Liu P; Zhang G; Chen Y; Deng K; Ye L Signal Transduct Target Ther 2020[Sep]; 5 (1): 180 PMID32879307show ga COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity including severe, moderate, mild, and asymptomatic, we observed the positive correlation between serum neutralizing capacity and disease severity, in particular, the highest NAb capacity in sera from the patients with severe disease, while a lack of ability of asymptomatic patients to mount competent NAbs. Furthermore, the compositions of NAb subtypes were also different between recovered patients with severe symptoms and with mild-to-moderate symptoms. These results reveal the tremendous heterogeneity of SARS-CoV-2-specific NAb responses and their correlations to disease severity, highlighting the needs of future vaccination in COVID-19 patients recovered from asymptomatic or mild illness. |Adult[MESH] |Antibodies, Neutralizing/*biosynthesis[MESH] |Antibodies, Viral/*biosynthesis[MESH] |Betacoronavirus/*immunology/pathogenicity[MESH] |COVID-19[MESH] |Case-Control Studies[MESH] |Convalescence[MESH] |Coronavirus Infections/blood/*immunology/*pathology/virology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Neutralization Tests[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*immunology/*pathology/virology[MESH] |SARS-CoV-2[MESH]Disease severity dictates SARS-CoV-2-specific neutralizing antibody re(epmc).pdf DeepDyve Pubget Overpricing